These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23141871)

  • 1. Performance of Quantiferon(®) for the diagnosis TB.
    Meyssonnier V; Guihot A; Chevet K; Veziris N; Assoumou L; Bourgarit A; Costagliola D; Caumes E; Carcelin G
    Med Mal Infect; 2012 Dec; 42(12):579-84. PubMed ID: 23141871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease.
    Idh J; Abate E; Westman A; Elias D; Janols H; Gelaw A; Getachew A; Alemu S; Aseffa A; Britton S; Stendahl O; Schön T
    Scand J Infect Dis; 2010 Sep; 42(9):650-7. PubMed ID: 20465490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.
    Moyo S; Isaacs F; Gelderbloem S; Verver S; Hawkridge AJ; Hatherill M; Tameris M; Geldenhuys H; Workman L; Pai M; Hussey G; Hanekom WA; Mahomed H
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1176-81, i. PubMed ID: 21943841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients.
    Jung JY; Lim JE; Lee HJ; Kim YM; Cho SN; Kim SK; Chang J; Kang YA
    J Infect; 2012 Feb; 64(2):188-96. PubMed ID: 22120597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis.
    Latorre I; Carrascosa JM; Vilavella M; Díaz J; Prat C; Domínguez J; Ferrándiz C
    J Infect; 2014 Dec; 69(6):600-6. PubMed ID: 25148944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
    Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
    Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
    Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
    Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays.
    Hsu DC; Zaunders JJ; Plit M; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey M; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD
    Tuberculosis (Edinb); 2012 Jul; 92(4):321-7. PubMed ID: 22542644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia.
    Niguse S; Desta K; Gebremichael G; Gebrezgeaxier A; Getahun M; Kassa D
    BMC Res Notes; 2018 May; 11(1):293. PubMed ID: 29751780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.